# Charles E. Larsen

> Charles E. Larsen is a Series C investor at Accuitive Medical Ventures backing Medical Device. See 4 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [Accuitive Medical Ventures](https://shizune.co/investors/profile/accuitive-medical-ventures)
- Location: Atlanta, United States
- Total investments: 4
- Last investment: Jul 2016
- Lead investor: 25%
- Last updated: Aug 2026

Charles E. Larsen is a Series C investor at Accuitive Medical Ventures in Atlanta focused on Medical Device and Health Care. Charles Larsen is the Co-Founder and Managing Director at AMV Partners.

## Contacts

5 contacts available for Charles E. Larsen: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/charles-e-larsen?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 3 | 75% |
| Health Care | 2 | 50% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 50% |
| Series D | 1 | 25% |
| Series E | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Torax Medical | Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota. | $25M | Series E | Jul 26, 2016 |  |
| Torax Medical | Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota. | $30M | Series D | Sep 19, 2012 |  |
| AqueSys | The Innovation Factory acquires novel medical technology ideas from individual inventors, corporations and universities, develops ideas comprehensively from proof of concept to FDA approval into marketable products, and then launches businesses around those products. We manage the complex path to market for early-stage medical device companies.With our deeply experienced management team and top-tier funding partners, we have assembled the intellectual, scientific, operational and financial resources needed to take a great idea from paper to production. Our nimble approach to both product and business development allows us to vet ideas properly and efficiently, maximizing predictability and speeding time-to-market while reducing risk for everyone involved.The Innovation Factory welcomes medical-related ideas and referrals from a variety of sources, and we promise confidentiality and timely response to all inquiries. For more information, please select the appropriate perspective: Inventor, University or Corporation. | $35M | Series C | Jun 02, 2010 |  |
| Sadra Medical | Sadra Medical is exploring new minimally invasive alternatives to traditional surgical valve replacement. The company hopes that devices allowing such procedural advances will facilitate and enhance treatment of aortic valve disease.Sadra Medical is dedicated to developing innovative new therapies for the treatment of aortic valve disease. Bydeveloping minimally invasive alternatives to traditional surgical valve replacement, the company seeks to help improve patient care and make valve replacement possible for broader range of patients. Treatment of aortic valve disease remains a significant and growing unmet clinical need. As many as 3 million people in U.S. have aortic valve stenosis; however, only a small percentage of those are treated with the current standard of care, valve replacement during open-heart surgery using cardiopulmonary bypass. By developing a highly effective aortic valve replacement that is designed to reduce the risks and morbidity associated with open surgical valve replacement, Sadra Medical seeks to provide a therapeutic option for patients who are not being treated today.Sadra Medical, a subsidiary of Boston Scientific. |  | Series C | May 22, 2009 |  |

4 of 4 investments shown.

## Co-investors
- [Kaiser Permanente Ventures](https://shizune.co/investors/profile/kaiser-permanente-ventures) — VC Fund, 2 deals together
- [Mayo Clinic Ventures](https://shizune.co/investors/profile/mayo-clinic-ventures) — VC Fund, 2 deals together
- [Sanderling Ventures](https://shizune.co/investors/profile/sanderling-ventures) — VC Fund, 2 deals together
- [Boston Scientific](https://shizune.co/investors/profile/boston-scientific) — VC Fund, 1 deal together
- [Finistere Ventures](https://shizune.co/investors/profile/finistere-ventures) — VC Fund, 1 deal together
- [Johnson & Johnson Robotics and Digital Solutions](https://shizune.co/investors/profile/johnson-johnson-innovation) — VC Fund, 1 deal together

## About Accuitive Medical Ventures

VC Fund · Duluth, United States

Accuitive Medical Ventures (AMV) is a medical device venture capital firm. AMV is in business to finance and help develop early and expansion stage medical device and technology companies.

5 contacts available at Accuitive Medical Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Charles E. Larsen | Co-Founder & Managing Director | — |
| Thomas D. Weldon | Co-Founder, Chairman, and Managing Director | — |
| Anthony Lando | Partner | — |
| Gerard van Hamel Platerink | Venture Partner & Co-Founder | https://shizune.co/investors/profile/gerard-van-hamel-platerink |
| Gordon T. Wyatt | CFO | — |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Charles E. Larsen invest in?

Charles E. Larsen invests primarily in Medical Device, Health Care and Biotechnology startups, most often at Series C and Series D stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Charles E. Larsen?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Charles E. Larsen last invest?

The most recent investment recorded for Charles E. Larsen closed in Jul 2016. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co